Found 21 matching trials
HS-IT101 Injection in the Treatment of Advanced Melanoma PHASE1 Single-arm, open-label,interventional study evaluating adoptive cell therap...
Show More Status
Enrolling By Invitation
Location
Peking University Cancer Hospital
Learn More & Join Trial
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors PHASE1 The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Show More Location
START Midwest/Cancer & Hematology Centers of Western Michigan, PC
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer PHASE1 This trial will enroll patients with locally advanced rectal cancer (resect...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
CRLX101 Plus Bevacizumab in Advanced RCC PHASE1 This is a Phase 1b, dose escalation study of the investigational agent, CRL...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer EARLY_PHASE1 Prospective, single-center, single-arm, open-label,interventional study eva...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer PHASE2 This research study is a Phase II clinical trial. In addition to studying s...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma PHASE2 This is a multicenter, randomized controlled, open-label Phase II clinical ...
Show More Location
Multiple Locations
Learn More & Join Trial
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment PHASE2 Background:
Some prostate cancer keeps growing even when testosterone in t...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) PHASE2 This study to evaluate treatment in patients with metastatic renal cell car...
Show More Location
University of California San Diego
Learn More & Join Trial
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer PHASE1 Background: EP0057 (formerly CRLX101) consists of a sugar molecule cyclodex...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial